Wada, M., Kukita, A., Sone, K., Hamamoto, R., Kaneko, S., Komatsu, M., . . . Fujii, T. (2020). Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer. MDPI AG.
Chicago Style (17th ed.) CitationWada, Miku, et al. Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer. MDPI AG, 2020.
MLA (8th ed.) CitationWada, Miku, et al. Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer. MDPI AG, 2020.
Warning: These citations may not always be 100% accurate.